How big is the Global Skin Cancer Diagnostics and Therapeutics Market?

The Global Skin Cancer Diagnostics and Therapeutics Market size is expected to reach USD 13.82 billion in 2024 and grow at a CAGR of 5.21% to reach USD 17.82 billion by 2029. Read More

What is the current Global Skin Cancer Diagnostics and Therapeutics Market size?

In 2024, the Global Skin Cancer Diagnostics and Therapeutics Market size is expected to reach USD 13.82 billion. Read More

Who are the key players in Global Skin Cancer Diagnostics and Therapeutics Market?

Amgen, Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, Merck & Co., Inc. and Sun Pharmaceutical Industries Ltd are the major companies operating in the Global Skin Cancer Diagnostics and Therapeutics Market. Read More

Which is the fastest growing region in Global Skin Cancer Diagnostics and Therapeutics Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Global Skin Cancer Diagnostics and Therapeutics Market?

In 2024, the North America accounts for the largest market share in Global Skin Cancer Diagnostics and Therapeutics Market. Read More

What years does this Global Skin Cancer Diagnostics and Therapeutics Market cover, and what was the market size in 2023?

In 2023, the Global Skin Cancer Diagnostics and Therapeutics Market size was estimated at USD 13.14 billion. The report covers the Global Skin Cancer Diagnostics and Therapeutics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Global Skin Cancer Diagnostics and Therapeutics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Skin Cancer Diagnostics and Therapeutics Market

Skin Cancer Diagnostics and Therapeutics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The Report Covers Skin Cancer Diagnostics and Therapeutics Market Growth Trends and is Segmented by Cancer Type (Melanoma and Non-melanoma), Type (Diagnosis (Dermatoscopy, Biopsy, Genetic Tests and Others) and Therapeutics (Chemotherapy, Immunotherapy, Targeted Therapy, and Others)), and Geography (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). The Market Size and Forecasts are Provided in terms of Value (in USD million) for the Above Segments.

Skin Cancer Diagnostics and Therapeutics Industry Overview

The skin cancer diagnostics and therapeutics market is competitive globally and regionally. The market consists of several major players who are engaged in continuous product development and launches. Some companies currently dominating the market are Abbott, Pfizer Inc., Sanofi SA, F. Hoffmann-La Roche Ltd, Labcorp., and sun pharmaceuticals industries limited, among others.